The protective effect of olanzapine on ketamine induced cognitive deficit and increased NR1 expression in rat model of schizophrenia.
Article in International Journal of Physiology, Pathophysiology and Pharmacology (April 2021)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment
Article in Pharmacological Reports (November 2020)
NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality
Article in International Journal of Molecular Sciences (March 2019)